Search filters

List of works by Michaela Liedtke

A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma

scientific article published on 25 May 2018

Daratumumab vs pomalidomide for the treatment of relapsed/refractory multiple myeloma: A cost-effectiveness analysis

scientific article published on 18 December 2018

Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis.

scientific article published on 14 June 2017

Efficacy and safety analysis by age cohort of inotuzumab ozogamicin in patients with relapsed or refractory acute lymphoblastic leukemia enrolled in INO-VATE.

scientific article

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome-positive relapsed/refractory acute lymphoblastic leukemia

scientific article published on 24 November 2020

Grading cardiac response in AL amyloidosis: implications for relapse and survival

scientific article published on 19 December 2018

Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study

scientific article published on 28 March 2019

Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone versus standard of care in MAMMOTH

scientific article published on 24 September 2020

Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin

scientific article published on 17 January 2019

Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma

scientific article published on 25 June 2018

Paulina is supported by:

About Paulina

Help